167 related articles for article (PubMed ID: 26852229)
1. Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.
Herteleer L; Zwarts L; Hens K; Forero D; Del-Favero J; Callaerts P
Psychopharmacology (Berl); 2016 May; 233(9):1751-62. PubMed ID: 26852229
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
Plant KE; Anderson E; Simecek N; Brown R; Forster S; Spinks J; Toms N; Gibson GG; Lyon J; Plant N
Toxicol Appl Pharmacol; 2009 Feb; 235(1):124-34. PubMed ID: 19101580
[TBL] [Abstract][Full Text] [Related]
4. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos.
Chen B; Wang JF; Hill BC; Young LT
Brain Res Mol Brain Res; 1999 Jun; 70(1):45-53. PubMed ID: 10381542
[TBL] [Abstract][Full Text] [Related]
5. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons.
Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH
Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid inhibits neurosphere formation by adult subventricular cells by a lithium-sensitive mechanism.
Zhou Q; Dalgard CL; Wynder C; Doughty ML
Neurosci Lett; 2011 Aug; 500(3):202-6. PubMed ID: 21741439
[TBL] [Abstract][Full Text] [Related]
7. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
8. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
[TBL] [Abstract][Full Text] [Related]
9. Effects of lithium chloride on the gene expression profiles in Drosophila heads.
Kasuya J; Kaas G; Kitamoto T
Neurosci Res; 2009 Aug; 64(4):413-20. PubMed ID: 19410610
[TBL] [Abstract][Full Text] [Related]
10. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila.
Dokucu ME; Yu L; Taghert PH
Neuropsychopharmacology; 2005 Dec; 30(12):2216-24. PubMed ID: 15956996
[TBL] [Abstract][Full Text] [Related]
11. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
Wang JF; Bown C; Young LT
Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
[TBL] [Abstract][Full Text] [Related]
12. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
Cui J; Shao L; Young LT; Wang JF
Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of sodium valproate in a serotonergic cell line reveals gene regulation through both HDAC inhibition-dependent and independent mechanisms.
Sinha P; Cree SL; Miller AL; Pearson JF; Kennedy MA
Pharmacogenomics J; 2021 Jun; 21(3):359-375. PubMed ID: 33649518
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats.
Rygula R; Golebiowska J; Kregiel J; Holuj M; Popik P
Psychopharmacology (Berl); 2015 Jun; 232(12):2149-56. PubMed ID: 25537337
[TBL] [Abstract][Full Text] [Related]
15. Identification of mood stabilizer-regulated genes by differential-display PCR.
Wang JF; Bown CD; Chen B; Young LT
Int J Neuropsychopharmacol; 2001 Mar; 4(1):65-74. PubMed ID: 11343631
[TBL] [Abstract][Full Text] [Related]
16. Lithium and valproate protect hippocampal slices against ATP-induced cell death.
Wilot LC; Bernardi A; Frozza RL; Marques AL; Cimarosti H; Salbego C; Rocha E; Battastini AM
Neurochem Res; 2007 Sep; 32(9):1539-46. PubMed ID: 17479365
[TBL] [Abstract][Full Text] [Related]
17. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
Gurvich N; Klein PS
Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
[TBL] [Abstract][Full Text] [Related]
18. Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development.
Hill EJ; Nagel DA; O'Neil JD; Torr E; Woehrling EK; Devitt A; Coleman MD
PLoS One; 2013; 8(3):e58822. PubMed ID: 23527032
[TBL] [Abstract][Full Text] [Related]
19. Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.
Wang SY; Ren M; Jiang HZ; Wang J; Jiang HQ; Yin X; Qi Y; Wang XD; Dong GT; Wang TH; Yang YQ; Feng HL
Neuroscience; 2015 Aug; 301():276-88. PubMed ID: 26067594
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers.
Perova T; Kwan M; Li PP; Warsh JJ
Int J Neuropsychopharmacol; 2010 Jul; 13(6):693-702. PubMed ID: 19400980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
